Rhythm

Bardy Diagnostics Carnation Ambulatory Monitor Patch decreases both time to diagnosis and readmissions in Emergency Department patients with possible arrhythmia concerns in Clinical Study from Overlake Medical Center

BELLEVUE, Wash., July 29, 2021 /PRNewswire/ — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation Ambulatory Monitor (CAM) patch was presented at the 2021 Heart Rhythm Society (HRS) Conference. The abstract, “Accelerating Proper Evaluation of Emergency Department Patients for Arrhythmia Concerns with Discharge Use of ECG Patch Monitors,” […]

Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring

AI Algorithms Enhance LINQ II™ Insertable Cardiac Monitor Diagnostic Accuracy for Improved Management of Patients DUBLIN, July 28, 2021 /PRNewswire(opens new window)/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ […]

BIOTRONIK’s Implantable Cardiac Monitor Receives Prestigious Industry Award

BIOMONITOR IIIm Received Frost & Sullivan’s ‘Enabling Technology Leadership Award’ 2021 for its High Precision Implantable Cardiac Monitoring BERLIN, July 28, 2021 /PRNewswire/ — In association with Heart Rhythm 2021, BIOTRONIK today announced that the latest implantable cardiac monitor (ICM), BIOMONITOR IIIm, has been recognized by internationally-renowned research analysts Frost & Sullivan as […]

New Study Demonstrates KardiaMobile 6L Reduces Urgent Healthcare Utilization

MOUNTAIN VIEW, Calif., July 27, 2021 /PRNewswire/ — A new study to be presented this week at Heart Rhythm 2021 and recently published in the American Journal of Cardiology1 shows use of the KardiaMobile 6L device results in a reduction of in-person healthcare utilization. The KardiaMobile 6L device was developed and is manufactured by AliveCor, an […]

Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology

Analysis in full patient cohort shows Gencaro effect compared to standard of care In the GENETIC-AF entire cohort of heart failure patients treated with Gencaro, compared to patients treated with metoprolol succinate (TOPROL-XL), experienced: a 36% reduction in cumulative atrial fibrillation burden with a 55% reduction in daily atrial fibrillation […]

AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias

Collaboration Aims to Explore Benefits of Remote Monitoring of Patients Pre- and Post-Ablation MOUNTAIN VIEW, Calif., July 27, 2021 /PRNewswire/ — AliveCor, Inc. (“AliveCor”), a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services, and Acutus Medical (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today […]

Medtronic TYRX™ Absorbable Antibacterial Envelope Is Effective at Reducing Infections in Cardiac Device Patients with Hematomas

DUBLIN, July 26, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from the landmark WRAP-IT study published in Heart Rhythm, demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the TYRX™ Absorbable Antibacterial Envelope (TYRX Envelope) is […]

Texas Cardiac Arrhythmia Institute leader participates in clinical trial for world’s first artificial intelligence technology for complex cardiac arrhythmia procedures

AUSTIN, Texas, July 22, 2021 /PRNewswire/ — The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently led a clinical study to evaluate the world’s first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures. Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, conducted the […]

Galaxy Medical’s ECLIPSE-AF Study 90 Day Remapping Results to be Featured at the 2021 Stanford Biodesign New Arrhythmia Technologies Retreat

SAN CARLOS, Calif., July 22, 2021 /PRNewswire/ — Galaxy Medical announced today that the 90 day remapping results of its ECLIPSE-AF study will be featured at the 2021 Stanford Biodesign New Arrhythmia Technologies Retreat on July 27th.  Ante Anić, M.D., Electrophysiology Laboratory Director at University Clinical Hospital in Split, Croatia, and primary investigator of […]

Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients

Company Signs Commercial Agreement with Bayer HealthCare SAS France to Accelerate Global Adoption and Improve Quality of Care for Heart Failure Patients Worldwide PARIS and CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ — Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the company is expanding its line of products and […]